Vol.58 No.S-1 March 2010

Phase I study of tazobactam/piperacillin in healthy volunteers

Kohya Shiba

Jpn. J. Chemother. 58 (S-1): 1-10, 2010

Clinical pharmacological study of tazobactam/piperacillin in patients with community-acquired pneumonia

Akira Watanabe, Nobuki Aoki, Yoshihito Niki, Atsushi Saito, Shigeru Kohno and Kohya Shiba

Jpn. J. Chemother. 58 (S-1): 11-28, 2010

Comparative phase III tazobactam/piperacillin and ceftazidime study in the treatment of community-acquired pneumonia

Akira Watanabe, Nobuki Aoki, Kingo Chida, Yoshihito Niki, Atsushi Saito, Shigeru Kohno, Jun-ichi Kadota and Kohya Shiba

Jpn. J. Chemother. 58 (S-1): 29-49, 2010

Multicenter open-label study of tazobactam/piperacillin in patients with hospital-acquired pneumonia

Naoki Aikawa, Atsushi Saito, Kazui Soma and Akira Watanabe

Jpn. J. Chemother. 58 (S-1): 50-61, 2010

Phase III tazobactam/piperacillin (1:8) study in patients with complicated urinary tract infection

Soichi Arakawa, Satoshi Ishihara, Masaya Oshi and Motoshi Kawahara

Jpn. J. Chemother. 58 (S-1): 62-72, 2010

Phase III tazobactam/piperacillin (1:8) study in patients with sepsis or infective endocarditis

Kohya Shiba, Satoshi Ishihara, Shin Kawai, Hiroshige Mikamo and Takashi Yokoyama

Jpn. J. Chemother. 58 (S-1): 73-87, 2010

Phase III clinical study of tazobactam/piperacillin (1:8) in pediatric patients with bacterial infection

Keisuke Sunakawa, Naoichi Iwai, Kazunobu Ouchi and Yoshitake Sato

Jpn. J. Chemother. 58 (S-1): 88-102, 2010